Monica Thomas
Human Resources Officer bei G1 THERAPEUTICS, INC.
Vermögen: 499 612 $ am 31.03.2024
Profil
Monica Roberts Thomas is currently working as the General Counsel, Chief Legal & People Officer at G1 Therapeutics, Inc. Previously, she worked as the Head-Corporate Legal at Radius Health, Inc. She completed her undergraduate degree at Duke University and her graduate degree at NCCU School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
G1 THERAPEUTICS, INC.
0,22% | 20.03.2024 | 115 651 ( 0,22% ) | 499 612 $ | 31.03.2024 |
Aktive Positionen von Monica Thomas
| Unternehmen | Position | Beginn |
|---|---|---|
| G1 THERAPEUTICS, INC. | Human Resources Officer | - |
Ehemalige bekannte Positionen von Monica Thomas
| Unternehmen | Position | Ende |
|---|---|---|
| RADIUS HEALTH, INC. | General Counsel | - |
Ausbildung von Monica Thomas
| Duke University | Undergraduate Degree |
| NCCU School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
